Announcement under Regulation 30(LODR) -Resignation of Chief Financial officer
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Mr. Pradip Kumar Sharma has resigned from the position of Chief Financial Officer (CFO) of Kimia Biosciences Limited, citing personal reasons. His resignation takes effect from the close of business hours on January 6, 2026. The company has confirmed he was designated as a Key Managerial Personnel under SEBI regulations. The intimation has been made to BSE (scrip code 530313) under Regulation 30 of the SEBI Listing Regulations. The company has not yet disclosed any replacement for the CFO role.
CFO exits at small-cap companies can create short-term uncertainty around financial reporting and continuity, though the resignation is attributed to personal reasons. Investors should watch for timely appointment of a new CFO to maintain governance stability.